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Abstract
Neisseria meningitidis has multiple strategies to evade complement-mediated killing, which
contribute to its ability to cause septicaemic disease and meningitis. However, the meningococcus
is primarily an obligate commensal of the human nasopharynx, and it is unclear why the bacterium
has evolved exquisite mechanisms to avoid host immunity. Here we demonstrate that mechanisms
of meningococcal immune evasion and resistance against complement increase in response to an
elevation in ambient temperature. We have identified three independent RNA thermosensors
located in the 5′-UTRs of genes necessary for capsule biosynthesis, the expression of factor H
binding protein, and sialylation of lipopolysaccharide, which are essential for meningococcal
resistance against immune killing1,2. Therefore increased temperature (which occurs during
inflammation) acts as a ‘danger signal’ for the meningococcus which enhances defence against
human immune killing. Infection with viral pathogens, such as influenza, leads to inflammation in
the nasopharynx with an elevated temperature and recruitment of immune effectors3,4.
Thermoregulation of immune defence could offer an adaptive advantage to the meningococcus
during co-infection with other pathogens, and promote the emergence of virulence in an otherwise
commensal bacterium.
Neisseria meningitidis is an obligate human pathogen and important cause of sepsis and
meningitis5, with peaks of disease often preceded by influenza outbreaks in temperate
climates6. The bacterium has evolved exquisite mechanisms to evade immune responses7,
including expression of a polysaccharide capsule (containing sialic acid in serogroup B, C,
Y and W strains)8,9, sialylation of lipopolysaccharide (LPS), and recruitment of the human
complement regulator factor H, via high affinity interactions with bacterial factor H binding
protein1-2. The reasons why such mechanisms have evolved in an otherwise commensal
bacterium is uncertain as systemic infection represents an evolutionary dead end.
Previously we found that resistance of the meningococcus against complement-mediated
killing is enhanced following insertion of the mobile element IS1301 into the 134 bp
intergenic region (IGR) between the css (encoding capsule biosynthesis) and ctr (capsule
export) operons in the capsule biosynthesis locus (cps)10,11. To identify other changes
modulating serum resistance, we subjected the N. meningitidis strain S311 to serial passage
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in 6% human serum; within six rounds, S3 became as resistant to complement-mediated
killing as a strain (R3) with IS1301 in the IGR (Supplementary Fig. 1). We further
characterised six passaged strains (selected serum resistant, SSR 1-6) that were more
resistant to complement than S3 (Fig. 1a). Resistance did not result from insertion of
IS1301; instead five strains (all except SSR2) have lost a single copy of a duplicated 8 nt.
sequence (TATACTTA) located 15 nt. upstream of the CssA start codon in the 5′-
untranslated region (5′-UTR) of css mRNA (Fig. 1b-c, Supplementary Fig. 2) and have
elevated levels of CssA, which catalyses the first step in capsule biosynthesis12. Comparison
of S3 with SSR, and isogenic strains (both containing an antibiotic resistance cassette
downstream of the css operon) with one (Δ8) or two copies (wild-type, WT) of the 8 bp
sequence demonstrates that loss of 8 bp causes elevated CssA levels and capsule expression
(Fig. 1d-e). The increased serum resistance of SSR2 resulted from reduced levels of PorA
(Fig. 1b), a target of bactericidal antibodies13.
To define how the 8 bp sequence contributes to capsule expression, we performed DNA
footprinting of the IGR with IHF and FIS. Despite potential recognition sites for these
proteins10,14, there was no difference in IHF or FIS binding to the WT and Δ8 IGRs
(Supplementary Fig. 3). Analysis of translational reporters in the N. meningitidis cps
demonstrated that loss of 8 bp leads to a marked increase in reporter activity of Css but not
Ctr (Supplementary Fig. 4 and 5), demonstrating that Δ8 influences the capsule biosynthesis
operon. Furthermore, significantly elevated Css reporter activity with the Δ8 IGR was
evident in 38 transcription factor mutants (Supplementary Table 1, Supplementary Fig. 5),
while northern blot analysis demonstrates that css mRNA levels are unaffected by the
number of copies of the 8 bp (Fig. 1f). Therefore, the 8 bp sequence affects CssA post-
transcriptionally.
We noticed that the css 5′-UTR is predicted to form a stem loop structure that includes the
ribosome binding site (RBS, Fig. 2a), consistent with an RNA thermosensor15. In RNA
thermosensors, the transcript assumes a hairpin structure at lower temperatures that occludes
the RBS, and stalls protein translation; higher temperatures destabilise the secondary
structure which allows translation. The Δ8 mRNA, on the other hand, is predicted to form a
limited stem loop with a single-stranded region by the RBS (Fig. 2a). Consistent with a
thermosensor, CssA levels increase in N. meningitidis grown at increasing temperatures
(Fig. 2b). In contrast, loss of 8 bp leads to increased CssA levels at lower temperatures and
less pronounced increase at higher temperatures, suggesting that this change disrupts the
thermosensor and dysregulates capsule biosynthesis.
RNA thermosensors should function in a heterologous host. Similar to N. meningitidis,
thermal regulation of CssA was evident in E. coli containing CssA and the WT IGR on a
plasmid; CssA expression was dysregulated with the Δ8 IGR (Fig. 2c). Additionally, in vitro
transcription/translation assays demonstrated that CssA synthesis increased with an
elevation in temperature and on loss of one copy of the 8 bp sequence (Fig. 2d) in the
absence of any transcription factor. Furthermore, we introduced nucleotide (nt.) changes into
the 5′-UTR predicted to alter the stability of the thermosensor, including substitutions at the
same position (+92U/C or +92U/G, Fig. 2a) expected to have opposing effects. Expression of
CssA from plasmids containing these changes was consistent with a thermosensor in the 5′-
UTR (Fig. 2e). We also performed RNA toeprinting at 30°C, 37°C and 42°C to assess
binding of ribosomes to the nascent css transcript. The results demonstrate that ribosome
binding is enhanced to mRNA from the Δ8 compared to WT 5′-UTR, with differences most
marked at 30°C (Supplementary Fig. 6). Finally we found that thermoregulation of CssA is
evident in strains of different capsular serogroups and hypervirulent lineages (Fig. 2f).
Together these results confirm the presence of an RNA thermosensor controlling the capsule
biosynthesis operon in N. meningitidis across a range of strains.
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Previous reports of RNA thermosensors in pathogens are restricted to facultative organisms
and govern transcription factors that mediate transition of bacteria from external to internal
environments15-18. As the meningococcus is an obligate commensal residing in the
nasopharynx, we compared the dynamic response of the canonical PrfA Listeria
thermosensor with the meningococcal Css thermosensor (which directs a single pathway).
The prfA and css 5′-UTRs and their promoters were fused to GFP in pEGFP-N2, and in
vitro transcription/translation was performed at different temperatures (Fig. 3a). Protein
synthesis regulated by the prfA thermosensor was barely detected up to 36°C, but markedly
increased at higher temperatures. In contrast to this on:off switching, the css thermosensor
displayed a gradual increase over physiologically relevant temperatures (acting like a
rheostat). The difference can be explained by the relatively high GC content and distribution
of GC bonds flanking the RBS in the prfA 5′-UTR (Fig. 3b); in the bacteria, the Listeria
thermosensor mediating a marked temperature shift as the bacterium migrates from the
external environment into its host, while N. meningitidis is in virtual constant contact with
its host and therefore be less exposed to large temperature wide temperature fluctuations.
Next we determined the prevalence of IGR polymorphisms in 265 meningococcal disease
isolates. The WT sequence (two copies of the 8 nt. sequence) was most frequently found
(201 of 265, 75.8%); of note, no polymorphism was detected in the 5′-UTR with two copies
of the 8 nt. Strains with a Δ8 accounted for the remainder (64/265, 24.2%, Fig. 3c), although
this deletion was accompanied by two substitutions (TATGCCTAT; altered bases
underlined, Δ8AT/GC) in the majority of instances (50/64 isolates, 78.1%). Only a few strains
(8/64, 12.5%) had the Δ8 sequence with no changes, and the single, TATGCTTAT
polymorphism (Δ8A/G) was present in the other strains (6 of 64, 9.4%), but TATACCTAT
(Δ8T/C) was never detected. We analysed the effect of these polymorphisms in E. coli
plasmid reporters (Fig. 3d), and found that whereas Δ8A/G partially restores CssA thermal
regulation following deletion of 8 nt., Δ8AT/GC re-establishes thermosensing (consistent with
its predicted structure and RNA toe-printing, Supplementary Fig. 6 and 7). In contrast, Δ8T/C
(which was never found) leads to markedly elevated CssA expression at all temperatures. Of
note, the compensatory polymorphisms occur at similar frequencies in different clonal
complexes of the meningococcus, consistent with them arising on several occasions.
The conservation of the WT sequence and prevalence of compensatory polymorphisms
emphasise the importance of capsule thermoregulation in the meningococcus. Hence we
examined whether other factors involved in immune escape are subject to similar regulation.
Of note, expression of factor H binding protein (which recruits the host complement
regulator factor H) and Lst (necessary for LPS sialylation19) also increase with increasing
temperature (Fig. 3e), in contrast to proteins not involved in immune escape (such as PorB,
Pilin, RmpM, and RecA) which are unaffected by temperature (Fig. 3f). To define the
mechanism of thermosensing of fHbp and Lst, we analysed in E. coli plasmids harbouring
these genes and observed thermal regulation (Fig. 4a). Furthermore, thermoregulation of
these proteins in N. meningitidis was independent of 38 transcription factors
(Supplementary Fig. 8), while thermoregulation of fHbp and Lst was detected in both in
vitro transcription/translation assays (with fixed amounts of DNA) and in vitro translation
assays (with fixed amounts of RNA, Fig. 4a) indicating that the 5′-UTRs of fHbp and lst
contain RNA thermosensors, consistent with secondary RNA structure predictions
(Supplementary Fig. 9).
Temperature therefore acts as a ‘danger signal’ for the meningococcus, prompting the
bacterium to enhance expression mechanisms of immune evasion via three independent
thermosensors dedicated to single proteins or pathways. To determine the influence of
temperature on meningococcal complement resistance, bacteria were grown at 30°C then
incubated at 30°C or 37°C for one hour. Bacteria that had been equilibrated at the elevated
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temperature expressed more CssA, fHbp, and Lst (Supplementary Fig. 10) and were
significantly more resistant against complement than those left at 30°C (Fig. 4b),
demonstrating that thermal regulation of immune defence mechanisms has a marked impact
on bacterial survival in the presence of human complement.
An elevation in temperature is a cardinal feature of inflammation, which is associated with
extravasation of serum components and recruitment of phagocytes. In these circumstances,
increasing expression of factors necessary for immune evasion would provide a considerable
adaptive advantage to a microbe in the nasopharynx (Fig. 4c). Influenza provokes
complement activation in the upper airway3, a rise in core temperature, and elaborates
neuraminidase that could damage the meningococcal capsule20. By sensing local
inflammation, thermal regulation of immune defence by the meningococcus would allow
adaption to changes in the nasopharynx during infection with influenza21,4 and other
respiratory pathogens; microbes unable to sense and protect themselves against
inflammatory responses will face elimination from this habitat (Fig. 4b). Furthermore,
thermoregulation by the meningococcus would provide an advantage to bacteria entering the
bloodstream, which is at higher temperatures than the nasopharynx22. Therefore traits that
are beneficial for bacterial colonisation during coinfection and inflammation (such as
thermoregulation of immune defence) will, by unfortunate coincidence, promote the
virulence of otherwise commensal microbes.
Materials and Methods
Bacterial Strains and Growth Conditions
Neisseria was grown in Brain Heart Infusion broth (BHI, Oxoid, 37 g dissolved in 1 L dH2O
with 1 g soluble starch) or on BHI agar (1% w/v) supplemented with Levinthal’s base (500
ml defibrinated horse blood, autoclaved with 1 L BHI broth). Solid media was inoculated
from frozen stocks of bacteria stored in media with 15% glycerol at −80°C. Cultures were
then incubated for 16–18 hours at 37°C with 5% CO2. Liquid cultures were grown in 10 ml
of media inoculated with 109 bacteria and grown at 37°C with shaking (150 r.p.m.) to an
optical density (O.D.) measured at 600 nm (A600) of ~0.4 unless otherwise stated. N.
meningitidis disease isolates belonging to serogroups B, C, W135, and Y from cc11, 32,
41/44, and 269 were described previously 1
E. coli was grown in Luria-Bertani (LB) broth (2% w/v in dH2O, Oxoid, UK) or on LB agar
(1% w/v) plates. All liquid E. coli cultures were grown in 5 ml of media inoculated from a
single colony overnight at 37°C with shaking (250 r.p.m.). Overnight grown bacteria were
diluted 1/100 in media and grown to an A600 of ~0.4 unless otherwise stated. To construct
isogenic strains, isolates were tagged with a kanamycin cassette in oatC as previously
described 2. Primers NG1095-for and NG1125-rev were used to amplify an 8 kb region
across the IGR and oatC using genomic DNA from SSR5 as DNA template; all primers are
shown in Supplementary Table 2. The PCR product was sequenced, purified and
transformed into S3. Eight transformants with the deletion and four without the deletion
were analysed to confirm the resistance phenotype. The porA gene was amplified and
sequenced with NG1945-for and NG1946-rev.
Plasmid DNA from E. coli was isolated from overnight cultures grown in LB broth using the
GenElute™ Plasmid Kit (Sigma-Aldrich). Genomic DNA from N. meningitidis was purified
as previously, and PCRs were performed using a PTC-225 Tetrad PCR machine (MJ
Research). DNA was purified using a QIAquick gel extraction kit (Qiagen, UK) and DNA
digestion was carried out using enzymes supplied by New England Biolabs, Ligation
reactions contained no more than 100 ng of purified vector and insert DNA (usually in a 1:3
ratio) and Quick-stick ligase (Bioline, UK). N. meningitidis was transformed by placing 10
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μl of a bacterial suspension on solid media, and allowing it to dry. Plasmid or genomic DNA
was added to the bacteria, and the plates were incubated for 4 hours at 37°C before streaking
on selective media.
N. meningitidis reporter strains
Reporter constructs for N. meningitidis were initially generated in pUC19 in E. coli as
follows. The erythromycin resistance cassette was amplified from pYHS1882 using NG1304
and NG1305. The resulting product and pUC19 were digested with AatII and Eco01091 and
ligated together. The resulting construct was digested with BsaI and AatII and ligated with a
region of the cssA ORF amplified using primers NG1306 and NG1307 and digested with the
same enzymes. Promoters of interest were then inserted upstream of the erythromycin
resistance cassette following HindIII and AflIII digestion. The promoter regions were
amplified from strains with primers NG1324 and NG1419. A truncated ctrA with no
intergenic region (IGR) was amplified with NG1419 and NG1420, and integrated into the
pUC19. Next the lacZα fragment was removed from the vector by digestion with HindIII
and SfoI, and replaced with full length lacZ amplified from pRS415 using NG1480 and
NG1484. The resulting fusions contained the cssA start codon fused to lacZ at codon 10.
Constructs were verified by restriction mapping and sequence analysis before transformation
of N. meningitidis. Integration of the vector by double crossover leads to a single
chromosomal copy of the lacZ reporter in the capsule biosynthesis locus. Template genomic
DNA was used with a WT or Δ8 IGR as appropriate.
Whole cell lysates, β-galactosidase assays and FACS analysis
N. meningitidis strains were harvested after overnight growth on BHI agar plates and re-
suspended in PBS. The concentration of the bacterial suspension was determined by
measuring the A260 of a mixture containing 20 μl of the bacterial suspension and 980 μl of
lysis buffer (0.1 M NaOH, 1% SDS) using a UVVIS spectrophotometer (Shimadzu UK).
The bacterial suspension was adjusted to 10 × 109 CFU/ml, mixed with an equal volume of
2× SDS-PAGE loading buffer (100 mM Tris-HCl pH 6.8, 20 μM β-mercaptoethanol, 4%
SDS, 0.2% bromophenol blue, 20% glycerol), and boiled for 10 minutes. The samples were
centrifuged at 16,000 ×g for 20 seconds, and 10 or 20μl of samples was analysed by SDS-
PAGE. β-galactosidase assays were performed as described previously 3 using o-
nitrophenyl-β-galactoside (ONPG) (4 mg/ml) as the substrate; reactions were stopped by the
addition of 1 M NaCO3. FACS analysis to determine the amount of capsule has been
described previously2. Results were calculated as mean fluorescence index (MFI), the
geometric mean multiplied by the percentage of positive cells.
SDS-PAGE and Western blotting
Proteins were separated on polyacrylamide gels alongside Precision Plus All Blue markers
(Biorad, USA) and stained using Coomassie blue stain for 10 minutes. Proteins were
transferred to immobolin P polyvinylidine fluoride (PVDF) membranes (Millipore, USA)
using the wet transfer system (Biorad, USA). For Western blot analysis, membranes were
washed three times in 0.05% (w/v) dry milk/PBS with 0.05% (v/v) Tween-20 for 10
minutes, and then incubated with the primary antibody for two hours. Membranes were
washed again three times and incubated for a further hour with a secondary, HRP-
conjugated antibody. Binding was detected with an ECL Western Blotting Detection kit
(Amersham, USA) and exposed to ECL Hyperfilm. Anti-peptide antibodies were generated
against CssA (amino acid sequences, YGRTYKEVTRENYQH or DVGTRQSNRHMGKSI,
Eurogentec), and used at a final dilution of 1:500. An α-RecA rabbit antibody (Bio
Academia, France) was used at a final dilution of 1:10,000. Goat α-rabbit IgG HRP-
conjugated antibody (Dako, UK) was used at a final dilution of 1;10,000, while the α-His-
HRP conjugated mAb (Qiagen, UK) was used at a 1:50,000 dilution. Antibodies were used
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at a final concentration as follows: α-PorB mAb (NIBSC), 1:1000; α-RmpM mouse mAb
(NIBSC), 1:1000; α-PilE mouse pAb, 1:5000; α-fHbp mouse pAb, 1:5000; α-Lst rabbit
pAb, 1:20000.
Screen of Transcription Factor Mutants
From the library of transcription factor mutants (Supplementary Table 1), genomic DNA
from each mutant was used to transform N. meningitidis containing css::lacZ translational
fusions of promoters. Colony PCR of transformants was used to verify the mutation of genes
encoding transcription factors. Once generated, the mutant library was analysed using the β-
galactosidase assay.
RNA Isolation and Northern analysis
N. meningitidis and E. coli were grown in liquid culture to an O.D. A600 of ~0.4 prior to
RNA extraction. RNA was isolated using the RNAeasy Miniprep Kit (Qiagen, UK)
following the manufacturer’s protocol. Samples was analysed by measuring the A260 and
A280. For northern blotting, 20μg of total RNA was separated on a formaldehyde agarose gel
prior to transfer. Hybond-N membranes were subsequently hybridised with 32Pɣ-labeled
DNA fragments amplified with corresponding primers. Northern blots were developed and
band intensities measured in a Fuji phosphorImager scanner. Primers used are listed in Table
2. To amplify a DNA fragment for detection of sscA and tmRNA, we used CssA-U with
CssA-U and ssrA-(EC)-F with ssrA-(EC)-R.
Electrophoretic Mobility Shift Assays
Plasmids used in Electrophoretic Mobility Shift Assays (EMSA) were generated by
amplifying a truncated region of the intergenic region (TR, +40 to +139, primers R1F and
R1R) or a full length region of the IGR (FL, −80 to +132, primers R2F and R2R) by PCR
from genomic DNA. PCR products were ligated into pGEM-T Easy (Promega), and inserts
end labelled using the Klenow fragment of DNA polymerase (New England Biolabs, UK)
and [α-32P] dCTP. Binding was performed in 20 mM Tris-HCl, pH7.5, 10 mM DTT, 15%
glycerol, 100 mM KCl and 0.05 mg/ml BSA. Dilutions of IHF and FIS were prepared in 1 ×
reaction buffer with 1 mg/ml BSA. Concentrations of salmon sperm DNA and proteins are
indicated. Control DNA included Tn10 and Himar 4.
Toe-print assay
Templates for in vitro transcription of WT, Δ8bp, and Δ8bpAT/GC were constructed by PCR
using the primers S3(TOE)T7F and S3(TOE)-new. In vitro transcription was performed
using the RiboMAX™ Large Scale RNA production sytems-SP6 and T7 kit as described by
the manufacturer (Promega). In vitro transcribed RNA was ethanol precipitated,
resuspended in formamide loading dye and separated on an 8% denaturing polyacrylamide
gel. The RNA was visualized by UV shadowing, excised from the gel and transferred to 300
μl 2M NH4Acetate. After overnight incubation at 14°C, the RNA was phenol extracted
followed by ethanol precipitation. Quantification was performed on a NanoPhotometer
(Implen). In vitro transcribed RNA was 5′-end-labelled using the KinaseMax kit as
described by the manufacturer (Ambion). Toe-printing experiments were performed in 10 μl
reactions with 0.5 pmol of WT, Δ8bp, and Δ8bpAT/GC. The RNA were pre-incubated at
either 30°C, 37°C or 42°C for 20 min and subsequently mixed with 0.6 pmol of 5′-end-
labelled S3(TOE)-new probe in a buffer containing 60mM NH4Cl, 10mM Tris-acetate [pH
7.5], 10mM DTT, 1 ml RNAguard and 100 mM dNTP. The mixture was incubated 2 min at
94°C and then placed on ice for 5 min and either at 30°C, 37°C or 42°C for 5 min. Two
different concentrations of 30S ribosomes (0.1 and 0.5 pmol) (E. coli MRE600) were added
followed by 10 min incubation. The mixture was supplemented with 10 mM uncharged
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tRNAfmet (Sigma) followed by 15 min incubation after which, 2U of AMV reverse
transcriptase was added. The reaction was stopped after 30 min by the addition of 10 μl
formamide loading dye. In parallel, sequencing reactions were prepared using S3(TOE)T7F
and S3(TOE)-new DNA as templates. The resulting DNA was separated on an 8%
denaturing polyacrylamide sequencing gel and the resulting toe-print was measured with a
Fuji phosphorImager scanner.
In vitro transcription/translation
One microgram of cssA-WT-gfp (PCR amplified using CssA-GFP-F(L) and CssA-6C-R
were inserted in pEGFP-N2) and prfA-gfp5 plasmids were in vitro transcribed in an E coli
S30 Extract system for Linear Templates in vitro Transcription/Translation Kit (Promega)
according to the manufacturer’s instructions. In brief, cssA-WT-gfp and prfA-gfp plasmids
were digested using NotI restriction enzyme and purified using QiAquick PCR purification
kit (Qiagen). One microgram of cssA-WT-gfp and prfA-gfp digested plasmids mixtures
were incubated at 28°C, 30°C, 32°C, 34°C, 36°C, 37°C and 38°C for 1 hour before
transferring onto ice for 5 min. Samples were acetone-precipitated, re-suspended in 1×
sample buffer, and separated on a 12% polyacrylamide gel before being transferred onto a
PVDF membrane using a semi-dry blotting apparatus (Biorad). Membranes were developed
following the protocol of the ECL western blotting kit (Amersham), using anti-GFP (BD-
living colours) as primary antibody and an HRP-conjugated anti-mouse as the secondary
antibody (Dako).
In vitro translation
Five microgram of RNA from E. coli containing either lst or fhbp (PCR amplified using
fhbp-F and fhbp-R or lst(c)-F and lst(c)-R were cloned in pGEM-T) plasmids were in vitro
translated with the E coli S30 Extract system for Linear Templates in vitro Transcription/
Translation Kit (Promega) according to the manufacturer’s instructions. The RNA mixtures
were incubated at either 30°C, 37°C or 42°C for 1 hour before transferring onto ice for 5
min. Samples were acetone-precipitated, re-suspended in 1× sample buffer, and separated on
a 12% polyacrylamide gel before being transferred onto a PVDF membrane using a semi-
dry blotting apparatus (Biorad). Development of the membrane essentially followed the
protocol of the ECL western blotting kit (Amersham), using anti-LST or anti-FHBP as the
primary antibody and HRP-conjugated anti-rabbit or anti-mouse, respectively, as secondary
antibody (Dako).
Human serum sensitivity assay
Bacterial strains were grown on BHI agar plates overnight and re-suspended in PBS.
Bacteria were diluted to a final concentration of 1 × 105 CFU/ml in DMEM-glutaMAX™
medium (Invitrogen, UK), and incubated with different concentrations of normal human sera
(NHS) at 37 °C in presence of 5% CO2 for 1 hour. Survival of bacteria in the presence of
sera was determined by plating 10 μl aliquots to BHI plates and counting the number of
colonies after overnight incubation. The percent survival was calculated by comparing the
number of colonies present in samples with serum to those without serum.
To compare the sensitivity of bacteria at different temperatures, N. meningitidis was grown
in BHI broth to mid-logarithmic phase at 30°C, then split and incubated at 30°C or 37°C for
a further 1 hour. 106 CFU were incubated with serial dilutions of pooled human immune
serum for either 10 or 20 mins, and the proportion of bacteria surviving was determined by
plating 10 μl aliquots onto BHI plates and counting the number of colonies after overnight
incubation; differences were analysed with the Student’s t- test.
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Fig. 1. Loss of an 8 bp increases capsule expression and complement resistance
Selected serum resistant strains (SSR1-6) demonstrate enhanced resistance in human serum
against complement-mediated killing (a), and increased expression of CssA (b, except
SSR2; RecA loading control) compared with the parental strain, S3. (c) The 134 bp css/ctr
intergenic region showing the ribosome binding site (RBS), transcriptional start sites
(arrows) and open reading frames, and location of the duplicated 8 bp sequence. (d)
Resistant strains exhibit increased capsule expression by FACS (MFI, Mean Fluorescence
Index). (e) CssA expression in isogenic strains with one or two copies of the 8 bp sequence.
(f) Northern blot analysis demonstrates that increased CssA levels are not associated with
elevated cssA mRNA. Findings were confirmed in three biological replicates. Error bars
show S.D. of experiments performed in triplicate.
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Fig. 2. Capsule gene expression is governed by an RNA thermosensor
(a) Predicted secondary structure of the css 5′-UTR with two (WT) or one copy of the 8 nt.
sequence (Δ8); the ribosome binding site is indicated. (b) Western blot analysis of CssA
levels in isogenic N. meningitidis strains with a wild-type IGR (WT) or containing a single
copy of the 8 bp sequence (Δ8) grown at different temperatures (indicated above each lane).
(c) Thermoregulation of CssA expression is detected in E. coli by western blot analysis, and
(d) by in vitro transcription/translation assays with purified E. coli RNA polymerase; β-
lactamase included as a control. (e) Mutational analysis of the 5′-UTR. E. coli expressing
CssA with modifications (shown in panel a) grown at temperatures indicated; the predicted
effects shown. (f) Thermoregulation of CssA is evident in N. meningitidis across different
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capsular serogroups and lineages (cc, clonal complex). Findings were confirmed with three
biological replicates.
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Fig. 3. Thermosensing of immune evasion mechanisms
(a) In vitro transcription/translation assays and (b) predicted structure of the Css and PrfA
thermosensors modulating GFP expression in E. coli at a range of temperatures. (c)
Sequence analysis of the IGR in different hypervirulent lineages; clonal complexes (cc)
shown. Loss of a copy of the 8 bp sequence (Δ 8) is associated with a 2 bp substitution in the
remaining single 8 bp sequence (i.e. Δ8AT/GC), which is never detected in a strain with two
copies of the 8 bp sequence. (d) Effect of the polymorphisms examined in E. coli; the most
abundant polymorphism Δ8AT/GC restores thermosensing to wild-type levels in the presence
of a single 8 bp sequence, whereas Δ8A/G substitution partially restore thermosensing; Δ8T/C
leads to higher CssA levels than Δ8. (e) Western blot analysis demonstrates that levels of
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proteins mediating immune evasion, fHbp and Lst, increase in N. meningitidis with an
elevation in temperature, (f) whereas other proteins (indicated) are unaffected. Blots are
representative of experiments performed on at least three occasions.
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Fig. 4. Temperature influences complement escape by N. meningitidis
(a) Thermoregulation of fHbp and Lst expression in i) E. coli reporters detected by Western
blot analysis; RecA, loading control, ii) in vitro transcription/translation assays, and iii) in
vitro translation assays of fHbp and Lst; RecA, expression control. Blots are representative
of experiments performed on at least three occasions. (b) Bacteria incubated for 1 hr at 37°C
are more resistant to complement-mediated killing than those at 30°C: the assay was
performed on four separate occasions and error bars represent the SEM; ** and ***, p<0.01
and <0.001 (Students T test). (c) Inflammation at the epithelial surface in the nasopharynx
(in response to viral co-infection) would increase local temperature and recruitment of
innate immune effectors. Thermoregulation of microbial defence mechanisms would prevent
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bystander killing and enhance systemic dissemination to warmer body sites that are replete
with immune effectors.
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